Home » Stocks » SSKN

STRATA Skin Sciences, Inc. (SSKN)

Stock Price: $1.46 USD 0.03 (2.10%)
Updated May 18, 2021 11:59 AM EDT - Market open
Market Cap 46.30M
Revenue (ttm) 22.19M
Net Income (ttm) -5.79M
Shares Out 33.80M
EPS (ttm) -0.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 18
Last Price $1.46
Previous Close $1.43
Change ($) 0.03
Change (%) 2.10%
Day's Open 1.42
Day's Range 1.40 - 1.46
Day's Volume 18,010
52-Week Range 1.05 - 2.84

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Strata Skin Sciences, Inc. (SSKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

HORSHAM, Pa., April 28, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketi...

2 weeks ago - GlobeNewsWire

HORSHAM, Pa., April 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for t...

1 month ago - GlobeNewsWire

Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of 50.00% and 0.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the st...

1 month ago - Zacks Investment Research

Shares of Strata Skin Sciences (NASDAQ:SSKN) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 0.00% year over year to ($0.01), which bea...

1 month ago - Benzinga

HORSHAM, Pa., March 24, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketi...

1 month ago - GlobeNewsWire

Strata Skin Sciences, Inc. (SSKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

AVENTURA, Fla.--(BUSINESS WIRE)--Accelmed fund II

2 months ago - Business Wire

Vitiligo Repigmentation Achieved in Five Treatments with XTRAC® Excimer Laser

2 months ago - GlobeNewsWire

HORSHAM, Pa., March 10, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing and marketin...

2 months ago - GlobeNewsWire

Strata Skin Sciences, Inc. (SSKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

New Agreement Expands STRATA's Global Reach and Brings Successful Recurring Revenue Model to the Chinese Dermatology Market New Agreement Expands STRATA's Global Reach and Brings Successful Recurring Re...

2 months ago - GlobeNewsWire

HORSHAM, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (the “Company”) a medical technology company in dermatology and plastic surgery dedicated to developing, commer...

2 months ago - GlobeNewsWire

Preliminary, unaudited fourth quarter revenues in the range of $6.6 million to $6.8 million  Preliminary, unaudited fourth quarter recurring revenues in the range of $5.0 million to $5.2 million Worldwi...

4 months ago - GlobeNewsWire

HORSHAM, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to develo...

4 months ago - GlobeNewsWire

HORSHAM, Pa., Dec. 28, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to develo...

4 months ago - GlobeNewsWire

STRATA Skin Sciences, Inc. (SSKN) CEO Dolev Rafaeli on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Shares of Strata Skin Sciences (NASDAQ:SSKN) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share fell 33.33% year over year to ($0.04), which were in line wit...

6 months ago - Benzinga

HORSHAM, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commerciali...

6 months ago - GlobeNewsWire

HORSHAM, Pa., Nov. 05, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commerciali...

6 months ago - GlobeNewsWire

HORSHAM, Pa., Nov. 03, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to develo...

6 months ago - GlobeNewsWire

Delivers fastest results with fewest adverse events compared to topical, traditional UV, biologic and systemic therapies  Providing a better solution for I ntegrated H ealth S ystems and Capitation heal...

6 months ago - GlobeNewsWire

Cigna Now Provides Insurance Coverage of Excimer Laser Therapy for the treatment of Vitiligo Cigna Now Provides Insurance Coverage of Excimer Laser Therapy for the treatment of Vitiligo

6 months ago - GlobeNewsWire

Company expanding global presence and introducing recurring business model in Japan Company expanding global presence and introducing recurring business model in Japan

8 months ago - GlobeNewsWire

HORSHAM, Penn., Sept. 08, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commer...

8 months ago - GlobeNewsWire

STRATA Skin Sciences' (SSKN) CEO Dolev Rafaeli on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Shares of Strata Skin Sciences (NASDAQ:SSKN) rose 7.7% in pre-market trading after the company reported Q2 results.

9 months ago - Benzinga

Recurring revenue for the second quarter of 2020 was $2.8 million, a 52.1% decrease over second quarter 2019 Total gross margins in the second quarter of 2020 was 48.7%, a 14.9% decrease over second qu...

9 months ago - GlobeNewsWire

HORSHAM, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to deve...

9 months ago - GlobeNewsWire

STRATA Skin Sciences's (SSKN) CEO Dr. Dolev Rafaeli on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Recurring revenue for the first quarter of 2020 grew 7.3% over first quarter 2019 Total gross margins in the first quarter of 2020 grew 3.8% over first quarter 2019  Global recurring revenue installed...

1 year ago - GlobeNewsWire

$2.0 million forgivable loan received Provides further business update - Initiating the Patient Outreach Program

1 year ago - GlobeNewsWire

Preliminary unaudited total revenue for the first quarter of 2020 is expected to be in the range of $6.7 and $6.9 million, consistent with guidance previously given Global recurring revenue installed b...

1 year ago - GlobeNewsWire

92% of participants achieved reduction in mPASI score of 75% or more after receiving Optimal Therapeutic Dose Therapy with the Multi-Micro Dose® diagnostic tip for the treatment of their plaque psoriasi...

1 year ago - GlobeNewsWire

STRATA Skin Sciences, Inc. (SSKN) Dolev Rafaeli on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

New features include increased power range, short-hair scalp tip and on-board database to improve patient safety, treatment efficiency and ease-of-use New features include increased power range, short-h...

1 year ago - GlobeNewsWire

Preliminary, unaudited fourth quarter revenues in the range of $8.8 million to $8.85 million

1 year ago - GlobeNewsWire

HORSHAM, Pa., Jan. 06, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to deve...

1 year ago - GlobeNewsWire

HORSHAM, Pa., Nov. 19, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to deve...

1 year ago - GlobeNewsWire

HORSHAM, Pa., Nov. 14, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing,...

1 year ago - GlobeNewsWire

STRATA Skin Sciences, Inc.'s (SSKN) CEO Dolev Rafaeli Hosts Business Update Call (Transcript)

1 year ago - Seeking Alpha

Company filed its Annual Report on Form 10-K for the year ended December 31, 2018

1 year ago - GlobeNewsWire

HORSHAM, Pa., Oct. 07, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (Nasdaq: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to deve...

1 year ago - GlobeNewsWire

HORSHAM, Pa., Sept. 10, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing...

1 year ago - GlobeNewsWire

HORSHAM, Pa., Aug. 28, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing,...

1 year ago - GlobeNewsWire

Strata Skin (SSKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 years ago - Zacks Investment Research

About SSKN

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of psoriasis, vitiligo, atopic dermatitis, eczema, and other skin disorders. The compa... [Read more...]

Industry
Medical Devices
IPO Date
Oct 28, 2005
CEO
Dolev Rafaeli
Employees
109
Stock Exchange
NASDAQ
Ticker Symbol
SSKN
Full Company Profile

Financial Performance

In 2020, SSKN's revenue was $23.09 million, a decrease of -26.90% compared to the previous year's $31.59 million. Losses were -$4.39 million, 22.2% more than in 2019.

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for SSKN stock is "Strong Buy." The 12-month stock price forecast is 4.00, which is an increase of 173.97% from the latest price.

Price Target
$4.00
(173.97% upside)
Analyst Consensus: Strong Buy